The gene expression level of MAP1LC3A, which also stands for ATG-8 or LC3-II, showed an increase in its expression level while receiving CAP and SN individually, while CAP and SN combination treatment significantly elevated the level (100 times) and clearly indicated the presence of autophagy induction in combination-treated melanoma groups. This evidence concerns the gene MAP1LC3A and melanoma.